Exploring the therapeutic potential of gut microbiota for treating liver diseases

A recent study led by Partha Chakrabarti, CSIR-Indian Institute of Chemical Biology, Kolkata, explores the therapeutic potential of gut microbiota in preventing non-alcoholic fatty liver disease (NAFLD). The study found that butyrate, a metabolite produced by gut bacteria, effectively reduces inflammation in liver macrophages, suggesting a potential treatment approach for NAFLD.
Posted on in Biochemistry, Health & Medicine, Cell Biology & Research